<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1617751</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Splenic macrophage functional profile and its role in the immunopathogenesis of canine visceral leishmaniasis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>de Souza</surname>
<given-names>Tain&#xe3; Lu&#xed;s</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3097666/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santiago</surname>
<given-names>Marta de Almeida</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>Francini Neves</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3097642/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Figueiredo</surname>
<given-names>Fabiano Borges</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1563630/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Junior</surname>
<given-names>Artur Augusto Velho Mendes</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3097681/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menezes</surname>
<given-names>Rodrigo Caldas</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/468633/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Porrozzi</surname>
<given-names>Renato</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Morgado</surname>
<given-names>Fernanda Nazar&#xe9;</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/543844/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laborat&#xf3;rio de Imunoparasitologia, Instituto Oswaldo Cruz, Funda&#xe7;&#xe3;o Oswaldo Cruz</institution>, <addr-line>Rio de Janeiro</addr-line>,&#xa0;<country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laborat&#xf3;rio de Protozoologia, Instituto Oswaldo Cruz, Funda&#xe7;&#xe3;o Oswaldo Cruz</institution>, <addr-line>Rio de Janeiro</addr-line>,&#xa0;<country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Laborat&#xf3;rio de Biologia Celular, Instituto Carlos Chagas, Funda&#xe7;&#xe3;o Oswaldo Cruz</institution>, <addr-line>Curitiba</addr-line>,&#xa0;<country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Laborat&#xf3;rio de Pesquisa Cl&#xed;nica em Dermatozoonoses em Animais Dom&#xe9;sticos, Instituto Nacional de Infectologia Evandro Chagas, Funda&#xe7;&#xe3;o Oswaldo Cruz</institution>, <addr-line>Rio de Janeiro</addr-line>,&#xa0;<country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: David Arranz-Sol&#xed;s, Complutense University of Madrid, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Alicia Ponte-Sucre, Central University of Venezuela, Venezuela</p>
<p>David Sacks, National Institutes of Health (NIH), United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Fernanda Nazar&#xe9; Morgado, <email xlink:href="mailto:morgado@ioc.fiocruz.br">morgado@ioc.fiocruz.br</email>; Renato Porrozzi, <email xlink:href="mailto:renato.porrozzi@ioc.fiocruz.br">renato.porrozzi@ioc.fiocruz.br</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1617751</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 de Souza, Santiago, Ribeiro, Figueiredo, Junior, Menezes, Porrozzi and Morgado</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>de Souza, Santiago, Ribeiro, Figueiredo, Junior, Menezes, Porrozzi and Morgado</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Visceral leishmaniasis (VL) represents a major public health challenge, with the spleen frequently identified as one of the primary target organs. Dogs recognized as urban reservoir hosts, commonly harbor chronic infections characterized by elevated parasite burdens across multiple tissues. This study aims to analyze functional markers of M1 and M2 responses, as well as PD-L1+ macrophages in the spleens of naturally infected dogs with Leishmania infantum, and to correlate these findings with splenic white pulp disorganization, parasitic load, and clinical severity.</p>
</sec>
<sec>
<title>Methods</title>
<p>Thirty-four VL-infected dogs were enrolled, each undergoing clinical evaluation to determine a clinical severity score. Histopathological analyses were performed to evaluate splenic white pulp disorganization, while quantitative PCR and immunohistochemistry were employed to assess parasite burden. Immunological markers were analyzed via immunohistochemistry, immunofluorescence, and flow cytometry.</p>
</sec>
<sec>
<title>Results</title>
<p>Splenic white pulp disorganization was observed in most animals, indicating marked tissue disruption. Immunostaining demonstrated the presence of NOS2<sup>+</sup>, Arginase 1<sup>+</sup>, pSTAT3<sup>+</sup>, CD206<sup>+</sup>, and TGF-&#x3b2;<sup>+</sup> cells, reflecting the engagement of both M1 and M2 macrophage subsets in the immune response, with a predominance of M1 profile. Elevated CD206 expression correlated with splenic white pulp disruption and parasite load. A notable finding was the decrease in the CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>Arginase-1<sup>+</sup> ratio in animals with higher parasite load. Additionally, significant PD-L1 expression was detected in macrophages within spleens exhibiting splenic white pulp disorganization, indicative of a pro-exhaustion cellular phenotype. Flow cytometry analysis identified co-expression of arginase-1 and PD-L1, as well as Arginase-1<sup>high</sup>+ cells. Finally, arginase-1high+ cells directly correlated with arginase-CD14-PD-L1<sup>+</sup> cells suggesting that not only macrophages, but others arginase-1high expressing cell types may contribute for suppressive/regulatory profile during the immunopathogenesis of canine VL.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The persistent presence of CD206, CD68<sup>+</sup>Arginase-1<sup>+</sup> and CD68<sup>+</sup>PD-L1<sup>+</sup> cells within the inflamed, parasitized splenic tissue, alongside a relative decline in CD68<sup>+</sup>NOS2<sup>+</sup> cells, may create a permissive environment for parasite survival and replication, thereby sustaining the inflammatory response. This chronic exposure to antigenic and inflammatory stimuli likely contributes to persistent tissue damage, exemplified by splenic white pulp disorganization in the spleen, and exacerbates disease progression.</p>
</sec>
</abstract>
<kwd-group>
<kwd>visceral leishmaniasis</kwd>
<kwd>dog</kwd>
<kwd>cell exhaustion</kwd>
<kwd>macrophage</kwd>
<kwd>spleen</kwd>
<kwd>M1 macrophages</kwd>
<kwd>M2 macrophages</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="40"/>
<page-count count="15"/>
<word-count count="6388"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Parasite Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Visceral Leishmaniasis (VL) is a major public health problem due to the large number of people at risk of infection and the high lethality when left untreated (<xref ref-type="bibr" rid="B1">1</xref>). In Brazil, it is caused by the protozoan <italic>Leishmania infantum</italic> (<xref ref-type="bibr" rid="B2">2</xref>), and human and animal cases are expanding geographically (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). In urban environments, domestic dogs are considered major reservoirs because they can harbor a high parasite load even in healthy skin (<xref ref-type="bibr" rid="B5">5</xref>), and the detection of canine cases often precedes the emergence of human cases (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Loss of parasite control correlates with a failure of the immune response in dogs (<xref ref-type="bibr" rid="B8">8</xref>). In Brazil, the treatment of infected dogs with meglumine antimoniate, the drug of choice for Human Visceral Leishmaniasis (HVL), is prohibited (<xref ref-type="bibr" rid="B9">9</xref>). However, in other countries, treatment is allowed (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>) but is often associated with a high relapse rate (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>). The transition from infection to active Canine Visceral Leishmaniasis (CVL) is marked by a prominent humoral response, suppression of cellular immunity, and the onset of clinical signs (<xref ref-type="bibr" rid="B13">13</xref>). Disease progression has been associated with splenic architectural disorganization (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>), increased parasite load, and decreased cytokine and chemokine expression (<xref ref-type="bibr" rid="B16">16</xref>). It was found in our previous studies that animals with high parasite loads exhibit not only follicular atrophy but also marked reductions in both pro- and anti-inflammatory cytokine mRNA expression (<xref ref-type="bibr" rid="B17">17</xref>), a profile consistent with cellular exhaustion.</p>
<p>T cell exhaustion, initially observed in chronic viral infections, is characterized by increased expression of the inhibitory receptor PD-1 (Programmed Death-1), often detectable early in infection (<xref ref-type="bibr" rid="B18">18</xref>). PD-1 expression is triggered by repeated antigenic stimulation in T and B lymphocytes, while its ligand, PD-L1, is constitutively expressed by B cells, T cells, macrophages, and dendritic cells in the spleen (<xref ref-type="bibr" rid="B19">19</xref>). PD-1 activation promotes apoptosis, inhibits proliferation, and suppresses cytokine production (<xref ref-type="bibr" rid="B20">20</xref>). In our previous research, we identified PD-1, TIM-3, LAG-3, and CTLA-4 expression in the spleens of infected dogs (<xref ref-type="bibr" rid="B21">21</xref>), and noted increased apoptotic CTLA-4<sup>+</sup> cells in disorganized spleens correlating with high parasite burden (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>The substantial parasite loads in advanced stages of infection (<xref ref-type="bibr" rid="B8">8</xref>), along with diminished lymphoproliferative responses, may involve immune suppression mechanisms such as IL-10 and TGF-&#x3b2; activity. Macrophages, the main host cells for <italic>Leishmania</italic>, may contribute to CVL immunopathogenesis. Disruption of the splenic white pulp may compromise not only CD4 T cells but also macrophage functionality.</p>
<p>Macrophages are the cells where <italic>Leishmania</italic> reproduces and survives for long periods (<xref ref-type="bibr" rid="B22">22</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>). A protective immune response against these parasites is predominantly introduced by Th1 cells, which are key to activating the macrophage oxidative stress machinery, resulting in the production of reactive oxygen and nitrogen species and disease control (<xref ref-type="bibr" rid="B25">25</xref>). NOS2 and arginase-1 share the same substrate (L-arginine), competing for its availability, and arginase inhibition in <italic>L. donovani</italic>-infected human macrophages enhances NOS2 expression and vice versa (<xref ref-type="bibr" rid="B26">26</xref>). While NOS2 is an important marker for M1 macrophage activation, Arginase-1 expression indicates an M2 phenotype. A recent review (<xref ref-type="bibr" rid="B27">27</xref>) explains that a balance between M1 and M2 macrophages is crucial: excessive M1 activation causes tissue damage, whereas a high M2 profile promotes parasite growth. CD206, the mannose receptor, is also used as a M2 profile marker (<xref ref-type="bibr" rid="B28">28</xref>). Macrophages and dendritic cells can express it as a surface receptor or in its soluble form (<xref ref-type="bibr" rid="B29">29</xref>). In acute liver failure, it can be considered a biomarker of severity (<xref ref-type="bibr" rid="B29">29</xref>). STAT3 is one of the transcription activator factors involved in the polarization of M2 macrophages (<xref ref-type="bibr" rid="B28">28</xref>). In visceral leishmaniasis, the expression of IFN-&#x3b3;, Arginase-1 and STAT3 impaired macrophage and T lymphocytes responses <italic>in vitro</italic> (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>M2 macrophages producing IL-10 and TGF-&#x3b2; have been identified in the spleens of dogs with VL (<xref ref-type="bibr" rid="B31">31</xref>), and PD-L1+ macrophages have been observed in the spleens of <italic>L. donovani</italic>-infected mice (<xref ref-type="bibr" rid="B32">32</xref>). Therefore, this study aims to analyze functional markers of M1 and M2 responses, as well as PD-L1+ macrophages, in the spleens of dogs naturally infected with <italic>Leishmania infantum</italic> and correlate these findings with splenic white pulp disorganization (SWPD), parasite load, and clinical scores.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Ethics statement</title>
<p>Dogs naturally infected with <italic>L. infantum</italic>, tested seropositive for anti-<italic>Leishmania</italic> antibodies by the rapid dual-path platform assay (TR DPP, Biomanguinhos, Fiocruz, Rio de Janeiro, Brazil) and by enzyme immunoassay (ELISA, Biomanguinhos, Fiocruz, Rio de Janeiro, Brazil) were included in the study and scheduled for euthanasia between 2013 and 2014 according to the guidelines of the Brazilian Ministry of Health. All dog owners provided formal written consent for their participation. Sample collection occurred during necropsies performed by veterinarians at the Laborat&#xf3;rio de Pesquisa Cl&#xed;nica em Dermatozoonoses em Animais Dom&#xe9;sticos-INI-Fiocruz (LAPCLIN-DERMZOO-INI/Fiocruz). This study received approval from the Comit&#xea; de &#xc9;tica em Uso de Animais (CEUA-Fiocruz) under license LW-54/13 and adhered to Brazilian Law 11794/08 and the guidelines of the Sociedade Brasileira de Ci&#xea;ncia em Animais de Laborat&#xf3;rio (SBCAL). The access to genetic heritage was registered under number AFB4BD9 on the SisGen platform.</p>
</sec>
<sec id="s2_2">
<title>Animals</title>
<p>Thirty-four dogs from Barra Mansa, Rio de Janeiro, Brazil, diagnosed with <italic>L. infantum</italic> infection and referred for mandatory euthanasia at the Evandro Chagas National Institute of Infectious Diseases (INI/FIOCRUZ) were included. Euthanasia was carried out by veterinarians according to the following protocol: a) Intravenous administration of 1.0% thiopental (Tiopentax<sup>&#xae;</sup>, Cristalia) at a dosage of 1.0mL/kg; and b) After confirming the absence of a corneal reflex induced by deep anesthesia, 10mL of 19.1% potassium chloride (Isofarma) was administered intravenously. Spleen and blood samples were collected during necropsy; clinical data were recorded beforehand by two veterinarians.</p>
</sec>
<sec id="s2_3">
<title>Clinical evaluation</title>
<p>Clinical signs of CVL were evaluated per established protocols (<xref ref-type="bibr" rid="B21">21</xref>), assessing dermatitis, onychogryphosis, ophthalmic changes, body condition loss, alopecia, and lymph adenomegaly. Each sign was graded from 0 (absent) to 3 (severe) (<xref ref-type="bibr" rid="B33">33</xref>), and the total clinical score was used to classify animals as having low (0&#x2013;2), moderate (3&#x2013;6), or high (7&#x2013;18) clinical severity.</p>
</sec>
<sec id="s2_4">
<title>Histopathological analysis</title>
<p>Spleen tissue fragments were formalin-fixed in a 10% formalin-buffered solution (Merck, Darmstadt, Germany) and embedded in paraffin (Synth, Diadema, Brazil). Histological sections (5 &#x3bc;m thick) were mounted on microscopic slides and stained with hematoxylin and eosin (Leica Biosystems, Newcastle Upon Tyne, UK) for subsequent analysis using an optical microscope (Zeiss, Oberkochen, Germany). The organization of the splenic lymphoid tissue, including the white pulp, marginal zone, and red pulp, was assessed as previously described (<xref ref-type="bibr" rid="B14">14</xref>). The white pulp was graded as follows: 1) Organized, characterized by a periarteriolar sheath, germinal centers, and distinct mantle and marginal zones. 2) Slightly disorganized, exhibiting some hyperplastic or hypoplastic changes resulting in a partial loss of definition of certain white pulp regions. 3) Moderately disorganized, with white pulp regions barely individualized or indistinct. 4) Intensely disorganized, where the follicular structure is scarcely distinguishable from the red pulp and the T cell area. Then, the quantification of lymphoid follicles per square millimeter of tissue was conducted. This evaluation considered both the presence or absence of follicles and the number of lymphoid follicles per field.</p>
</sec>
<sec id="s2_5">
<title>Extraction of DNA from splenic tissue</title>
<p>Total DNA was extracted from approximately 10 mg of spleen using the QIAmp DNA Mini Kit (Qiagen, Santa Clarita, USA), so involving an initial digestion step with proteinase K (20 mg/mL) for 1 hour at 56&#xb0;C. The DNA was then eluted in TE buffer and quantified using a NanoDrop<sup>&#xae;</sup> spectrophotometer (Thermo Fisher Scientific, Waltham, USA).</p>
</sec>
<sec id="s2_6">
<title>Determination of the parasite load by qPCR</title>
<p>Parasite load in the spleen was quantified using real-time PCR following established protocols (<xref ref-type="bibr" rid="B17">17</xref>). HPRT primers (see <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Table S1</bold>
</xref>) were used to normalize the canine DNA content in each sample. Quantification of
<italic>Leishmania</italic> DNA was performed using primers targeting the small subunit ribosomal RNA (ssrRNA) gene, a multi-copy gene commonly used for parasite detection (<xref ref-type="bibr" rid="B34">34</xref>) (see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>).</p>
<p>qPCR assays were conducted using a Step One instrument (Applied Biosystems, Molecular Probes, Inc., Foster City, USA) with Power SYBR Green Master Mix (Applied Biosystems, Molecular Probes, Inc., Foster City, USA). Two microliters of purified total DNA (100 ng) were added to a final PCR volume of 20 &#x3bc;l, containing Power SYBR Green 1X and 300 nM of each primer for HPRT PCR assays or 500 nM of each primer for ssrRNA PCR assays. The qPCR protocol involved an activation step at 95&#xb0;C for 10 minutes, followed by 40 cycles of denaturation and annealing/extension (95&#xb0;C for 15 seconds, 60&#xb0;C for 1 minute, and 68&#xb0;C for 30 seconds).</p>
<p>A standard curve was generated for each target. All reactions were performed in duplicate for each target, and both targets were run on the same plate for the same sample. For quantification, peripheral blood mononuclear cells (PBMCs) from uninfected dogs and bulk cultures of <italic>L. infantum</italic> promastigotes (strain MCAN/BR/2007/CG-1) were used. PBMCs and promastigotes were quantified using a cell counter (Z1&#x2122; COULTER COUNTER<sup>&#xae;</sup>, Beckman Coulter, Fullerton, USA), and total DNA was extracted from 1x10<sup>6</sup> PBMCs and 1x10<sup>7</sup> promastigotes. Standard curves for the HPRT and ssrRNA genes were prepared using 10-fold serial dilutions. The animals were then categorized into high or low-parasite load groups based on previously established criteria (<xref ref-type="bibr" rid="B17">17</xref>).</p>
</sec>
<sec id="s2_7">
<title>Immunohistochemistry</title>
<p>Spleen tissue fragments were embedded in Tissue-Tek OCT resin (Sakura, Alphen aan den Rijn, The Netherlands) and sectioned at a thickness of 5 &#x3bc;m. Sections were mounted on silanized slides (Dako, Carpinteria, CA, USA) using acetone P.A. (Merck), then hydrated in phosphate-buffered saline (PBS) for 10 minutes. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide (Dako) for 1 minute at room temperature. After two 5-minute washes in PBS, non-specific binding was blocked with 0.4% bovine serum albumin (BSA) for 20 minutes at room temperature.</p>
<p>Excess blocking solution was removed, and primary antibodies targeting CD68 (macrophages), CD206 (mannose receptor), NOS2 (nitric oxide synthase 2), TGF-&#x3b2; (transforming growth factor beta), and <italic>Leishmania</italic> amastigotes were applied. Sections were incubated with primary antibodies for 18 hours at 4&#xb0;C. Control sections were prepared by omitting the primary antibody.</p>
<p>After incubation, sections were washed twice in PBS (5 minutes each) and incubated with the appropriate biotinylated secondary antibody (Dako) for 25 minutes, followed by two more PBS washes. Streptavidin-peroxidase (Genetex) was then applied for 25 minutes. After additional PBS washes, the immunoreactivity was visualized using an AEC substrate kit (Invitrogen, Carlsbad, USA). The reaction was stopped with type II water upon microscopic visualization. Slides were counterstained with Meyer&#x2019;s hematoxylin (Sigma-Aldrich, Saint Louis, USA) and mounted in Faramount medium (Dako).</p>
<p>Quantification of NOS2, CD206, and TGF-&#x3b2; positive cells was performed in five fields per spleen section at 40&#xd7; magnification. Amastigote quantification was performed in 20 fields at 1000&#xd7; magnification. Results are expressed as the median percentage and range (minimum to maximum) of positive cells or positive cells per square millimeter. Qualitative analyses were performed in both the red and white pulp regions.</p>
</sec>
<sec id="s2_8">
<title>Immunofluorescence</title>
<p>Immunofluorescence was conducted as previously described (<xref ref-type="bibr" rid="B21">21</xref>). Briefly, splenic tissue sections were fixed in acetone P.A. (Merck) and blocked to reduce non-specific antibody binding. The sections were then incubated with primary antibodies targeting macrophages (Bio-Rad, USA), pSTAT-3, arginase-1 (Cell Signaling Technology, USA), NOS2, PD-L1, CD68 (Abcam, USA), and <italic>L. infantum</italic> antigen. Secondary anti-mouse IgG antibodies conjugated with phycoerythrin (PE-red) and fluorescein isothiocyanate (FITC) were used, along with anti-mouse IgG conjugated with Dylight 633 and anti-mouse IgG conjugated with Dylight 488 or Alexa fluor 488. Slides were mounted with Fluoromount-G medium containing DAPI (4&#x2032;, 6-diamino-2-phenylindole) (Thermo Fisher Scientific) and examined using a fluorescence microscope. Image processing and overlay analyses were performed using ImageJ software (NIH, USA). The brightness and contrast were adjusted.</p>
</sec>
<sec id="s2_9">
<title>Flow cytometry</title>
<p>Splenocytes were isolated from 1 cm splenic fragments through mechanical disruption and successive washings, then cryopreserved in a solution of 90% fetal bovine serum (FBS) and 10% dimethyl sulfoxide (DMSO; Sigma) and stored in liquid nitrogen until further analysis. Thawing was performed at 37&#xb0;C, followed by the gradual addition of RPMI medium supplemented with 20% FBS (1 mL to 4 mL increments) at one-minute intervals. Cells were subsequently centrifuged at 1800 rpm for 10 minutes at 7&#xb0;C to remove the supernatant and resuspended in 5 mL of RPMI with 20% FBS. Following homogenization, an additional 5 mL of RPMI with 20% FBS was added. The samples were centrifugated for 10 minutes at 1800 rpm at 7&#xb0;C. Cells were incubated on ice for 20 minutes in a blocking solution containing 10% goat serum and 10% FBS to block Fc receptors. After centrifugation, cell viability, and concentration were assessed using a Neubauer chamber and Trypan blue exclusion method and adjusted to 1&#xd7;10<sup>7</sup> cells/mL. Only samples exhibiting a viability greater than 60% proceeded to the labeling protocol.</p>
<p>Cell viability was assessed using the Zombie Aqua dye (Invitrogen) for flow cytometry. A total of 1&#xd7;10<sup>6</sup> cells per tube were washed with 200 &#xb5;L PBS and incubated with 100 &#xb5;L of Zombie dye for 20 minutes at room temperature. After washing with PBS, surface staining was conducted. The primary anti-PD-L1 antibody (Biolegend, USA) was incubated for 20 minutes at 4&#xb0;C. After washing with PBS/BSA (PBS containing 0.1% BSA, 0.05% sodium azide), the secondary anti-mouse PE antibody (Invitrogen) was added and incubated for 20 minutes at 4&#xb0;C. After another wash with PBS/BSA, the anti-CD14-APC antibody (BD Biosciences, USA) was added and incubated for 20 minutes at 4&#xb0;C. Cells were then fixed and permeabilized using Cytofix/Cytoperm solution (BD), followed by washing with a permeabilization buffer (PBS/BSA containing 0.5% saponin). Intracellular staining was performed by resuspending cells in 30 &#xb5;L of the permeabilization buffer and incubating with anti-arginase-1 PE-Cyanine 7 antibody (Invitrogen) for 30 minutes at 4&#xb0;C. After a final wash, samples were washed and resuspended in PBS for acquisition in the flow cytometer.</p>
<p>Flow cytometric analysis was performed on a 12-color CytoFLEX flow cytometer equipped with 405 nm, 488 nm, 565 nm, and 638 nm lasers (Beckman Coulter, Brea, CA, USA) at the Multi-user Research Facility of Flow Cytometry &#x2013; Multiparametric Analysis, Instituto Oswaldo Cruz, FIOCRUZ. Data acquisition was managed using CytExpert software (Beckman Coulter). Fluorochromes were analyzed as follows: PE and PE-Cy7 (excited by 565 nm laser) with filters 585/42 and 780/60, respectively; APC (excited by 638 nm laser) with filter 660/10; and Zombie Aqua (excited by 405 nm laser) with filter 525/40.</p>
<p>Data analysis was conducted using FlowJo software version 7.6.5 (Becton Dickinson, Franklin
Lakes, NJ, USA). Initial gating was based on forward scatter (FSC) versus side scatter (SSC) to
delineate the cell population, followed by the exclusion of doublets via FSC-A <italic>vs</italic>. FSC-H gating (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). Viability was determined using a histogram of Zombie Aqua staining, and only samples greater than 50% viable cells were included. From the live cell population (Zombie-negative, live gate), expression levels of CD14, arginase-1, and PD-L1 were quantified. Single, dual, and triple expression profiles were assessed using the combination gating tool in FlowJo. The combination gating tool is an automatically combination of gates defined in simple analyses which permits all possible combinations (positive/negative), creating &#x2018;AND&#x2019;, &#x2018;OR&#x2019; and &#x2018;NOT&#x2019; populations for each antibody, resulting in different cell phenotypes&#x2019;.</p>
</sec>
<sec id="s2_10">
<title>Statistical analysis</title>
<p>A non-probabilistic sampling approach was employed in this study, with animals classified into three groups based on clinical presentation: (1) low clinical score, (2) moderate clinical score, and (3) high clinical score. Furthermore, animals were stratified according to the degree of organization in splenic lymphoid tissue: (1) organized (ranging from well-organized to mildly disorganized splenic white pulp) and (2) disorganized (ranging from moderately to severely disrupted splenic white pulp). Additionally, animals were categorized based on parasite burden: (1) low and (2) high.</p>
<p>The Shapiro&#x2013;Wilk test was applied to assess the normality of data distribution. For nonparametric data, comparisons between independent groups were conducted using the Mann&#x2013;Whitney U test or Kruskal&#x2013;Wallis test followed by Dunn&#x2019;s <italic>post hoc</italic> test. For parametric data, analyses were performed using the unpaired Student&#x2019;s t-test or one-way ANOVA followed by Tukey&#x2019;s multiple comparisons test. Correlations were assessed using either Pearson&#x2019;s or Spearman&#x2019;s rank correlation coefficient, as appropriate. Statistical analyses were conducted using GraphPad Prism version 8.0 (GraphPad Software, San Diego, CA, USA). A p-value less than 0.05 was considered statistically significant. Results are expressed as median and range (minimum&#x2013;maximum).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Clinical score, parasite load and splenic white pulp disorganization in dogs naturally infected with <italic>L. infantum</italic>
</title>
<p>Thirty-four dogs naturally infected with <italic>L. infantum</italic> were enrolled in this study. The groups were homogeneously distributed according to age and sex, as presented in the <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The distribution of sex and age across the study groups.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" colspan="5" align="center">Clinical Score</th>
</tr>
<tr>
<th valign="top" align="left">Clinical Data</th>
<th valign="top" align="left">Low</th>
<th valign="top" colspan="2" align="left">Medium</th>
<th valign="top" align="left">High</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="5" align="left">&#x2003;Sex (number)</th>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2003;Male</td>
<td valign="top" align="left">6</td>
<td valign="top" colspan="2" align="left">8</td>
<td valign="top" align="left">6</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2003;Female</td>
<td valign="top" align="left">6</td>
<td valign="top" colspan="2" align="left">7</td>
<td valign="top" align="left">7</td>
</tr>
<tr>
<th valign="top" align="left">&#x2003;Age (Years)*</th>
<th valign="top" align="left">3.23 &#xb1; 2.82</th>
<th valign="top" colspan="2" align="left">5.17 &#xb1; 3.54</th>
<th valign="top" align="left">4.23 &#xb1; 2.52</th>
</tr>
</tbody>
<tbody>
<tr>
<th valign="top" colspan="5" align="center">Parasite load</th>
</tr>
<tr>
<th valign="top" align="left">Clinical Data</th>
<th valign="top" colspan="2" align="left">Low parasite load</th>
<th valign="top" colspan="2" align="left">High parasiteload</th>
</tr>
</tbody>
<tbody>
<tr>
<th valign="top" colspan="5" align="left">&#x2003;Sex (number)</th>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2003;Male</td>
<td valign="top" colspan="2" align="left">10</td>
<td valign="top" colspan="2" align="left">10</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2003;Female</td>
<td valign="top" colspan="2" align="left">10</td>
<td valign="top" colspan="2" align="left">10</td>
</tr>
<tr>
<th valign="top" align="left">&#x2003;Age (Years)**</th>
<th valign="top" colspan="2" align="left">4.25 &#xb1; 3.29</th>
<th valign="top" colspan="2" align="left">4.16 &#xb1; 2.72</th>
</tr>
</tbody>
<tbody>
<tr>
<th valign="top" colspan="5" align="center">Splenic White Pulp Organization</th>
</tr>
<tr>
<th valign="top" align="left">Clinical Data</th>
<th valign="top" colspan="2" align="left">Organized to&#xa0;slight disorganization</th>
<th valign="top" colspan="2" align="left">Moderate to&#xa0;intense disorganization</th>
</tr>
</tbody>
<tbody>
<tr>
<th valign="top" colspan="5" align="left">&#x2003;Sex</th>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2003;Male</td>
<td valign="top" colspan="2" align="left">7</td>
<td valign="top" colspan="2" align="left">13</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2003;Female</td>
<td valign="top" colspan="2" align="left">8</td>
<td valign="top" colspan="2" align="left">13</td>
</tr>
<tr>
<th valign="top" align="left">&#x2003;Age(Years)***</th>
<th valign="top" colspan="2" align="left">3.13 &#xb1; 1.81</th>
<th valign="top" colspan="2" align="left">4.94 &#xb1; 3.44</th>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*p = 0.29 (oneway anova); **p= 0.07 (T-test); ***p = 0.93 (T-test).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The most frequently observed clinical manifestations of Canine Visceral Leishmaniasis (CVL) &#x2013; including dermatitis, alopecia, onycogryphosis, keratoconjunctivitis, lymphadenomegaly, and poor body condition &#x2013; were evaluated.</p>
<p>Based on the severity of these clinical signs, the animals were categorized into three groups: low (n = 10), medium (n = 13), and high clinical score (n = 11), as previously described (<xref ref-type="bibr" rid="B21">21</xref>). Additionally, splenic parasite burden was quantified, and animals were categorized into low (n = 18) and high (n = 16) parasite load groups.</p>
<p>Disorganization of the splenic white pulp was assessed and defined by reducing the number and compartmentalization of lymphoid follicles and the periarteriolar lymphoid sheath (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). A significant proportion of the animals (30/34; 75%) exhibited varying degrees of white pulp disorganization, ranging from mild (n = 9), moderate (n = 10), to severe (n = 11). This histopathological alteration appears to be a common feature and potentially associated with the progression of CVL (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Representative images of the different degrees of splenic white pulp organization/disorganization. <bold>(A)</bold> organized splenic white pulp; <bold>(B)</bold> slightly disorganized splenic white pulp; <bold>(C)</bold> moderately disorganized splenic white pulp; <bold>(D)</bold> severely disorganized splenic white pulp. RP, red pulp; WP, white pulp; CA, central arteriole; PALS, periarteriolar lymphatic sheath; GC, germinal center.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g001.tif">
<alt-text content-type="machine-generated">Histological images of spleen tissues at different magnifications labeled A to D. Panel A shows a clear germinal center with labels for central arteriole (CA), periarteriolar lymphoid sheath (PALS), germinal center (GC), red pulp (RP), and white pulp (WP). Panels B to D show spleen tissues with varying densities and distributions of cells, highlighting structural differences in the tissue samples.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<title>Increased presence of CD206<sup>+</sup> cells in the spleen of dogs naturally infected with <italic>L. infantum</italic> in relation to splenic white pulp disorganization</title>
<p>Immunohistochemical analysis was performed on splenic sections to detect and quantify the expression of NOS2, TGF-&#x3b2;, and CD206 (mannose receptor), along with the presence of <italic>Leishmania</italic> amastigotes (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM2">
<bold>Supplementary Table S2</bold>
</xref>). Positive cells for NOS2, CD206, and TGF-&#x3b2; were observed in all animals, indicating
the involvement of distinct macrophage profiles in the response to <italic>L. infantum</italic> infection. Overall, NOS2<sup>+</sup> cells were the most prevalent, compared to CD206<sup>+</sup> and TGF-&#x3b2;<sup>+</sup> markers (<xref ref-type="supplementary-material" rid="SM2">
<bold>Supplementary Table S2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Immunohistochemical Analysis of Spleen Tissue from Dogs Naturally Infected with <italic>Leishmania infantum</italic> for the Detection of Nitric Oxide Synthase 2 (NOS2), CD206, and <italic>L. infantum</italic> Amastigotes. <bold>(A)</bold> negative control, <bold>(B)</bold> nitric oxide synthase 2 (NOS2) and zoom, <bold>(C)</bold> CD206 (mannose receptor) and zoom, <bold>(D)</bold> amastigotes and antigens of L.infantum and zoom in the spleen of naturally infected dogs. Positive cells stained in red. Magnification bar: <bold>(A-C)</bold> 25&#xb5;m; <bold>(D)</bold> 10 &#xb5;m. <bold>(E)</bold> percentage of CD206<sup>+</sup> cells according to splenic white pulp disorganization; <bold>(F)</bold> percent of CD206+ cells according to parasite load; <bold>(G)</bold> percent of CD206<sup>+</sup> cells according to clinical score; <bold>(H)</bold> Positive correlation between CD206<sup>+</sup>cells/mm2 and amastigotes/mm2. <bold>(E,&#xa0;F)</bold> Unpaired t-test. <bold>(G)</bold> One-way ANOVA. <bold>(H)</bold> Pearson correlation. Quantification of NOS2 and CD206 positive cells was performed in five fields per spleen section at 40&#xd7; magnification. A total of 500 cells were counted as positive or negative cells. The percentage was calculated as (positive cells x 100) &#xf7; total counted cells.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g002.tif">
<alt-text content-type="machine-generated">Microscopic images and scatter plots show spleen samples and statistical data. A) Negative control. B) NOS2 expression. C) CD206 expression. D) Presence of amastigotes. E) Scatter plot of CD206 in organized versus disorganized splenic white pulp. F) CD206 percentage comparing low and high parasite loads. G) CD206 percentage across clinical scores. H) Correlation between CD206/mm&#xb2; and amastigotes density, showing a Pearson correlation of 0.795.</alt-text>
</graphic>
</fig>
<p>We observed two types of CD206 labeling: cellular labeling predominantly in macrophages, but also diffuse labeling in the extracellular medium. Notably, a significantly greater number of CD206<sup>+</sup> cells was detected in spleens with moderate to severe white pulp disorganization compared to those with preserved or slightly altered architecture (p = 0.048; unpaired t-test) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). No statistically significant differences were found in CD206<sup>+</sup> cell counts when stratified by clinical score or parasite load. However, there was a correlation between CD206/mm<sup>2</sup> and amastigotes/mm<sup>2</sup> (p &lt; 0.000; r = 0.795) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2H</bold>
</xref>).</p>
<p>Macrophage polarization was further assessed via immunofluorescence. During this analysis, macrophages (CD68<sup>+</sup> cells) co-expressing phosphorylated STAT-3, arginase-1, or NOS2 were identified (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). No significant differences were detected in the frequencies of
CD68<sup>+</sup>pSTAT-3<sup>+</sup>, CD68<sup>+</sup>arginase-1<sup>+</sup>, or CD68<sup>+</sup>NOS2<sup>+</sup> cells across groups categorized by splenic white pulp organization, clinical score, or parasite burden (<xref ref-type="supplementary-material" rid="SM2">
<bold>Supplementary Table S2</bold>
</xref>). However, a positive correlation was observed between CD68<sup>+</sup>pSTAT-3<sup>+</sup> and CD68<sup>+</sup>arginase-1<sup>+</sup> cell frequencies (p = 0.046; r = 0.361; Spearman&#x2019;s correlation).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Detection of Macrophages expressing pSTAT3, Arginase-1, or NOS2 in the spleen of dogs naturally infected with <italic>L. infantum</italic>. <bold>(A, D, G)</bold> CD68<sup>+</sup> cells (Macrophages/PE); <bold>(B)</bold> pSTAT-3 (FITC); <bold>(E)</bold> arginase-1 (FITC); <bold>(H)</bold> NOS2 (FITC); <bold>(C, F, I)</bold> overlapping images and zoom (PE/FITC/DAPI). Magnification bar: 25&#xb5;m. <bold>(J)</bold> Correlation between CD68<sup>+</sup>STAT3<sup>+</sup> and CD68<sup>+</sup>arginase-1<sup>+</sup> cells (Spearman correlation). <bold>(K)</bold> CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>arginase-1+ cells ratio according to clinical score (Kruskal-Wallis test); <bold>(L)</bold> CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>arginase-1+ cells ratio according to splenic white pulp disorganization (Mann-Whitney test). <bold>(K, L)</bold> The ratio was obtained by dividing the %CD68+NOS2+ cells by %CD68+arginase+ cells for each animal.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g003.tif">
<alt-text content-type="machine-generated">Fluorescence microscopy images show DAPI-stained cells expressing CD68 in red and co-stained with STAT3P, Arginase 1, and NOS2 in green. Panels A-C highlight CD68 and STAT3P, D-F show CD68 and Arginase 1, while G-I display CD68 and NOS2. Small insets provide zoomed views of marked regions. Graph J presents a scatter plot of %CD68+STAT3P+ cells versus %CD68+Arginase+1+. Graph L shows CD68+NOS2+/CD68+Arginase+1+ ratio across clinical scores, and Graph M compares the ratio in organized versus disorganized splenic white pulp. Statistical significances are indicated with p-values.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<title>Reduced CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>arginase-1<sup>+</sup> cell ratio in the spleens of dogs with elevated parasite load</title>
<p>By using immunofluorescence analysis of spleen sections at 100&#xd7; magnification, the co-localization of arginase-1<sup>+</sup> macrophages and <italic>Leishmania infantum</italic> amastigotes was confirmed (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). This observation indicates that arginase-1<sup>+</sup> macrophages are phagocytic and capable of harboring intracellular amastigotes (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Notably, amastigotes were also detected in arginase-1<sup>&#x2212;</sup> cells.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Co-localization of Arginase-1<sup>+</sup> Cells and <italic>Leishmania infantum</italic> Amastigotes in the Spleens of Naturally Infected Dogs. <bold>(A)</bold> Amastigotes (Alexa Fluor 488); <bold>(B)</bold> Arginase-1<sup>+</sup> cells (DyLight 633); <bold>(C)</bold> Merged image (Alexa Fluor 488/DyLight 633/DAPI). <bold>(D)</bold> Amastigote density (amastigotes/mm&#xb2;) stratified by clinical score (Kruskal&#x2013;Wallis test); <bold>(E)</bold> Amastigote density according to splenic white pulp disorganization (Mann&#x2013;Whitney test); <bold>(F)</bold> CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>Arginase-1<sup>+</sup> cell ratio based on parasite load (Mann&#x2013;Whitney test). The ratio was obtained by dividing the %CD68+NOS2+ cells by %CD68+arginase+ cells for each animal.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g004.tif">
<alt-text content-type="machine-generated">Fluorescence microscopy images and graphs relate to amastigote and arginase1 presence in tissue samples. Images A, B, and C show stained tissue with green amastigotes, red arginase1, and blue DAPI nuclear stain. Graph D plots amastigotes per square millimeter against clinical scores, showing no significant correlation (p = 0.63). Graph E compares amastigotes in organized versus disorganized splenic white pulp (p = 0.28). Graph F examines the ratio of CD68+NOS2+ to CD68+Arginase1+ in relation to parasite load, with a significant difference marked (p = 0.044).</alt-text>
</graphic>
</fig>
<p>No statistically significant differences in amastigote density (amastigotes/mm&#xb2;) were observed across groups stratified by clinical score or splenic white pulp organization (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4D, E</bold>
</xref>). However, animals exhibiting a high parasite load demonstrated a significantly reduced CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>Arginase-1<sup>+</sup> cell ratio (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Ratio of NOS2<sup>+</sup> Macrophages to Arginase-1<sup>+</sup> Macrophages according to splenic white pulp organization, parasite load, and clinical score in dogs naturally infected with <italic>Leishmania infantum</italic>.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" colspan="6" align="center">Clinical Score</th>
</tr>
<tr>
<th valign="top" align="left">Ratio</th>
<th valign="top" align="center">Low</th>
<th valign="top" colspan="2" align="center">Medium</th>
<th valign="top" align="center">High</th>
<th valign="top" align="center">p-value (Kruskal-Wallis)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">NOS2/arginase-1 ratio in macrophages/%**</td>
<td valign="top" align="left">1.19 (1.0 &#x2013; 1.52)</td>
<td valign="top" colspan="2" align="left">1.33 (0.87 &#x2013; 2.51)</td>
<td valign="top" align="left">1.14 (0.75 &#x2013; 2.8)</td>
<td valign="top" align="left">0.78</td>
</tr>
<tr>
<th valign="top" colspan="6" align="center">Parasite Load</th>
</tr>
<tr>
<th valign="top" align="left">Ratio</th>
<th valign="top" colspan="2" align="center">Low parasite load</th>
<th valign="top" colspan="2" align="center">High parasite load</th>
<th valign="top" align="center">p-value (Mann-Whitney)</th>
</tr>
<tr>
<td valign="top" align="left">NOS2/arginase-1 ratio in macrophages/%**</td>
<td valign="top" colspan="2" align="left">1.3 (1.0 &#x2013; 2.8)</td>
<td valign="top" colspan="2" align="left">1.11 (0.75 &#x2013; 2.21)</td>
<td valign="top" align="left">
<bold>0.045</bold>
</td>
</tr>
<tr>
<th valign="top" colspan="6" align="center">Splenic White Pulp Organization</th>
</tr>
<tr>
<th valign="top" align="center"/>
<th valign="top" colspan="2" align="left">Organized to slight disorganization</th>
<th valign="top" colspan="2" align="left">Moderate to intense disorganization</th>
<th valign="top" align="left">p-value (Mann-Whitney))</th>
</tr>
<tr>
<td valign="top" align="left">NOS2/arginase-1 ratio in macrophages/%**</td>
<td valign="top" colspan="2" align="left">1.19 (0.96 &#x2013; 2.8)</td>
<td valign="top" colspan="2" align="left">1.27 (0.75 &#x2013; 2.51)</td>
<td valign="top" align="left">0.44</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Data are represented as median (minimum-maximum values).</p>
</fn>
<fn>
<p>** Data obtained using immunofluorescence.P-value &lt; 0.05 is represented in bold.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<title>CD68<sup>+</sup>PD-L1<sup>+</sup> cells were detected in the spleen of dogs naturally infected with <italic>L. infantum</italic>
</title>
<p>Immunofluorescence analysis of spleen sections at 40&#xd7; magnification revealed <italic>in situ</italic> expression of the exhaustion marker PD-L1 on macrophages (CD68<sup>+</sup>) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). A trend towards elevated PD-L1 expression was observed in animals exhibiting disorganized splenic white pulp (p = 0.053; Mann&#x2013;Whitney test) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5F</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Immunofluorescence detection of macrophages expressing PD-L1 in spleen sections of dogs naturally infected with <italic>L. infantum</italic>. <bold>(A)</bold> DAPI, <bold>(B)</bold> CD68 (FITC), <bold>(C)</bold> PD-L1 (PE), and <bold>(D)</bold> merged images (FITC/PE/DAPI). Scale bar: 25 &#xb5;m. Quantification of CD68<sup>+</sup>/PD-L1<sup>+</sup> cells per mm&#xb2; according to <bold>(E)</bold> clinical score (Kruskal&#x2013;Wallis test), <bold>(F)</bold> splenic white pulp disorganization (Mann&#x2013;Whitney test), and <bold>(G)</bold> parasite load (Mann&#x2013;Whitney test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g005.tif">
<alt-text content-type="machine-generated">Fluorescence microscopy images labeled A-D and corresponding graphs E-G. Image A shows DAPI staining in blue. Image B shows FITC-labeled CD68 in green. Image C shows PE-labeled PD-L1 in red. Image D is a merged image showing co-localization indicated by yellow arrows, with a zoomed-in section. Graphs E-G display scatter plots of CD68+PD-L1+ cells per mm&#xb2; across different clinical scores, splenic white pulp organization, and parasite load, showing variability among the scores and conditions.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>Monocyte infiltration in the spleen is reduced with disease progression</title>
<p>To assess monocyte recruitment in the spleen, CD14<sup>+</sup> cells were quantified via flow
cytometry, alongside the co-expression of arginase-1 and PD-L1 (<xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary Table S3</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). A decrease in the frequency of CD14<sup>+</sup> cells (p = 0.055; one-way ANOVA) and CD14<sup>+</sup>arginase-1<sup>&#x2212;</sup>PD-L1<sup>&#x2212;</sup> cells (p = 0.048; Kruskal&#x2013;Wallis test) was observed in dogs with a high clinical score (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>). Furthermore, significant correlations were found between CD14<sup>+</sup> and arginase-1<sup>+</sup> cells (p = 0.001; r = 0.623; Spearman correlation), as well as between CD14<sup>+</sup>arginase-1<sup>+</sup>PD-L1<sup>&#x2212;</sup> and CD14<sup>&#x2212;</sup>arginase-1<sup>+</sup>PD-L1<sup>+</sup> cell populations (p = 0.034; r = 0.443; Spearman correlation) (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6C, D</bold>
</xref>). In Panel C, the correlation occurs between CD14<sup>+</sup> cells and total cells expressing arginase-1. Note that the percentage values (X-axis of Panel C) are much higher than those in Panel D because it includes not only M2 cells but also various leukocytes expressing the enzyme, including lymphocytes and neutrophils. In Panel D, the correlation occurs between CD14<sup>+</sup>Arginase-1<sup>+</sup>PD-L1<sup>-</sup> cells and CD14<sup>-</sup>Arginase-1<sup>+</sup>PD-L1<sup>+</sup> cells. Notice that the percentages are much lower, as it represents only a fraction of the population demonstrated in Panel C.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Flow cytometry analysis of splenic cells to detect CD14<sup>+</sup>, PD-L1<sup>+</sup> and arginase-1<sup>+</sup> cells according to clinical score. <bold>(A)</bold> Percentage of CD14<sup>+</sup> cells according to clinical score (Kruskal-Wallis test). <bold>(B)</bold> Percentage of CD14<sup>+</sup>PD-L1<sup>-</sup>Arginase-1<sup>-</sup> according to clinical score (Kruskal-Wallis test). <bold>(C)</bold> Correlation between %CD14<sup>+</sup> and %arginase-1<sup>+</sup> cells (Spearman correlation). <bold>(D)</bold> Correlation between CD14<sup>+</sup>arginase-1<sup>+</sup>PD-L1<sup>-</sup> and CD14<sup>-</sup>arginase-1<sup>+</sup>PD-L1<sup>+</sup> cells.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g006.tif">
<alt-text content-type="machine-generated">Graphs A and B show data distribution of %CD14 and %Arginase-CD14+PDL1- against clinical scores, with p-values of 0.055 and 0.048, respectively. Graphs C and D depict positive correlations, with r-values of 0.623 and 0.443, between %CD14 and %Arginase, and %Arginase+CD14+PDL1+ and %Arginase+CD14+PDL1-, respectively.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<title>Flow cytometry analysis reveals the presence of arginase-1<sup>high</sup> cells in the spleen of infected dogs and correlations between arginase-1<sup>high</sup> and PD-L1 exhaustion pathway</title>
<p>Flow cytometric analysis revealed the presence of arginase-1<sup>high</sup> and
arginase-1<sup>+</sup>PD-L1<sup>+</sup> co-expressing cells in the spleens of naturally infected
dogs (<xref ref-type="supplementary-material" rid="SM3">
<bold>Supplementary Table S3</bold>
</xref>). Although some of them were CD14<sup>+</sup> cells, it was not possible to define the other arginase-1<sup>high</sup> cells due to the absence of additional profile markers in our experiments. No statistically significant differences were observed according to clinical score, parasite load and splenic white pulp organization groups (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). However, a correlation between CD14<sup>-</sup>arginase-1<sup>-</sup>PD-L1<sup>+</sup> and arginase-1<sup>high</sup> cells was observed (p = 0.002; r = 0.605, Spearman correlation) (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Percentage of Arginase-1<sup>high</sup> cells according to <bold>(A)</bold> clinical score (Kruskal-Wallis test); <bold>(B)</bold> splenic white pulp disorganization (Unpaired t test); <bold>(C)</bold> parasite load (Mann-Whitney test). <bold>(D)</bold> correlation between CD14<sup>-</sup>arginase-1<sup>-</sup>PD-L1<sup>+</sup> and arginase-1<sup>high</sup> cells (Spearman correlation).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1617751-g007.tif">
<alt-text content-type="machine-generated">Four scatter plots labeled A, B, C, and D analyze %Arginase high. Plot A compares clinical scores, showing clusters at low, moderate, and high scores with p = 0.17. Plot B compares organized and disorganized splenic white pulp with p = 0.26. Plot C evaluates low and high parasite load with p = 0.066. Plot D shows a positive correlation between %Arginase high and %Arginase CD14-PDL1+ with p = 0.002 and r = 0.605.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>This study presents a comprehensive immunopathological evaluation of macrophage focused regulation and pro-exhaustion profiles in the spleens of 34 dogs naturally infected with <italic>Leishmania infantum</italic>. Through integrated analysis of clinical data, splenic white pulp disorganization (SWPD), and parasite load quantification, we demonstrate concurrent activation of both M1 (NOS2<sup>+</sup>) and M2 (TGF-&#x3b2;<sup>+</sup>, CD206<sup>+</sup>, Arginase-1<sup>+</sup>, pSTAT3<sup>+</sup>) macrophage phenotypes in infected spleens. Notably, elevated CD206 expression correlated with SWPD severity and parasite load, suggesting a pivotal role for M2 polarization in canine visceral leishmaniasis (CVL) immunopathogenesis. A lower CD68<sup>+</sup>NOS2<sup>+</sup>/CD68<sup>+</sup>arginase-1<sup>+</sup> cells ratio was observed in spleens from dogs with high parasite load, indicating a potential role of M1/M2 balance in the failure to control <italic>Leishmania</italic> replication. Since NOS2 is directly associated with nitric oxide (NO) production&#x2014;a key effector molecule for macrophage-mediated parasite killing&#x2014;while arginase-1 promotes polyamine production that supports parasite replication (<xref ref-type="bibr" rid="B35">35</xref>), a reduction in this ratio may favor <italic>Leishmania</italic> survival, even in the context of intense inflammation within the spleen. In this context, arginase-1 expression by macrophages was consistently high across all groups. Amastigotes were observed infecting both arginase-1-positive and -negative cells. Arginase-1, by converting arginine into ornithine and polyamines, creates a favorable microenvironment for the replication of <italic>Leishmania</italic> spp (<xref ref-type="bibr" rid="B32">32</xref>). Thus, the presence of arginase-1<sup>+</sup> cells amid the intense inflammatory infiltrate suggests that these macrophages may serve as protected replication niches for the parasite. This could promote persistent infection and continuous immune stimulation, contributing to chronic tissue damage characterized by splenic white pulp disorganization. Our data suggest a strong Th2/M2 immune profile in the spleens of dogs with VL caused by <italic>L. infantum</italic>, which may promote parasite replication and reflect an immunosuppressive microenvironment. Herein, we evidenced a positive correlation between CD206<sup>+</sup> cells and amastigotes. Notably, both CD68<sup>+</sup>PD-L1<sup>+</sup> and CD206<sup>+</sup> cells were more abundant in animals with disorganized splenic white pulp. This aligns with findings in a murine model of cysticercosis, a helminth infection, where early M2 differentiation was capable of suppressing T-cell responses via PD-L1 and PD-L2 through direct cell-cell interaction (<xref ref-type="bibr" rid="B36">36</xref>). The authors suggested that the stimulation of M2 differentiation deactivates the damaging inflammatory response (<xref ref-type="bibr" rid="B36">36</xref>), and maybe parasites like <italic>Taenia</italic> sp or <italic>Leishmania</italic> sp might exploit such regulatory mechanisms to escape immune clearance and ensure persistence. It has been hypothesized that during chronic <italic>Leishmania</italic> infection, excessive arginase-1 release by macrophages could contribute to T lymphocytes exhaustion (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>In our study, we observed for the first time a high arginase-1-expressing cell population positively correlated with PD-L1 expression, indicating a possible synergistic role between the arginase-1<sup>high</sup> expressing cells and exhaustion pathways. Some of these were identified as CD14<sup>+</sup>, however other CD14<sup>-</sup> cells could also express arginase-1<sup>high</sup>. The data suggest that not only macrophages, but others arginase-1<sup>high</sup> expressing cell types may contribute for suppressive/regulatory profile during immunopathogenesis of canine visceral leishmaniasis. Future studies are needed to really answer this hypothesis and to identify which cells is expressing arginase-1<sup>high</sup> since we were not able to characterize this population. Interestingly, previous studies in HIV-1-infected patients and inflammatory myopathies have reported PD-L1<sup>+</sup>/arginase-1<sup>+</sup> neutrophils (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). In inflammatory myopathies, myeloid-derived suppressor cells (MDSCs)&#x2014;comprising monocytes and polymorphonuclear cells&#x2014;co-expressing PD-L1 and arginase-1 were associated with disease progression (<xref ref-type="bibr" rid="B37">37</xref>). The authors demonstrated the PD-L1 and arginase-1 co-expression, as well as arginase-1<sup>high</sup> expression by MDSCs (<xref ref-type="bibr" rid="B39">39</xref>). Maybe these cells could also play a role in immunopathogenesis of visceral leishmaniasis since inflammatory persistent stimulus can generate these immature myeloid cells with regulatory functions. Further investigation is needed to test this hypothesis.</p>
<p>In the present study we also demonstrated pSTAT3 expression in CD68<sup>+</sup> cells in the spleen of dogs with CVL, with a significant correlation with the arginase-1 pathway. Studies showed a direct correlation between pSTAT3-mediated regulation of PD-L1 expression in tumor cells <italic>in vitro</italic> (<xref ref-type="bibr" rid="B40">40</xref>). In addition, the silencing of this protein negatively regulated PD-L1 expression in tumor cells and resulted in a direction towards an M1 phenotype of tumor-associated macrophages marked by elevated MHC II expression (<xref ref-type="bibr" rid="B40">40</xref>). In our study, the correlation between arginase-1 expression and PD-L1<sup>+</sup> cells corroborating the potential interaction by M2 and exhaustion pathways, and the possible impact of them in immunopathogenesis and parasite survival. These pathways may be activated due to various factors associated with the inflammatory process generated by <italic>L. infantum</italic> infection or directly by the parasite itself (<xref ref-type="bibr" rid="B38">38</xref>).</p>
<p>We hypothesized that even in small quantities, a PD-L1<sup>+</sup> cell can engage PD-1 receptors in multiple lymphocytes, triggering the process of cellular exhaustion. According to the literature, <italic>in vitro</italic> and <italic>in vivo</italic> blockade of PD-L1 resulted in decreased parasite survival and increased production of IL-12, TNF, ROS, and NO by macrophages (<xref ref-type="bibr" rid="B39">39</xref>) indicating that <italic>Leishmania</italic> parasites take advantage of the PD-1 pathway not only for T cell exhaustion, but also to prevent macrophage killing mechanisms and death, thus favoring parasite persistence. The authors showed the blockade of PD-L1 reduces arginase-1 in macrophages and polyamine availability to parasites, and favors proinflammatory macrophage activation and <italic>Leishmania</italic> control. Herein, a tendency to increased expression of PD-L1<sup>+</sup> macrophages was observed in dogs with disorganized spleen microarchitecture, suggesting a role of exhaustion pathway in the immunopathogenesis of CVL and parasite persistence.</p>
<p>As future trends, we seek to identify profile and functional markers for M1 and M2 macrophages that would allow the evaluation of parasite load in both cell types. In this sense, quantifying the number of infected cells and the number of amastigotes per macrophage with distinct profiles could contribute to the understanding of spleen infection in naturally infected dogs. Similarly, we aim to identify specific markers for dogs to assess the role of immature myeloid cells in this process. These cells express high levels of arginase-1 and PD-L1 and are involved in the pathogenesis of various inflammatory diseases (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Their role in visceral leishmaniasis has not yet been verified. We believe that the arginase-1 and cellular exhaustion pathways stimulate each other and constitute interesting targets for immunomodulation in visceral leishmaniasis.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>There is a fine balance between M1 and M2 cells, and as the disease progresses, these populations become quantitatively closer. However, When the parasitic load is lower, there is a predominance of M1 cells. The persistence and expansion of cell populations displaying an M2-like phenotype (e.g., CD206<sup>+</sup>, arginase-1<sup>+</sup>, pSTAT3<sup>+</sup>, TGF-&#x3b2;<sup>+</sup>) within the intense inflammatory infiltrate of spleens parasitized by <italic>Leishmania</italic> may be a key factor in parasite persistence and the chronic stimulation of the immune response in naturally infected dogs. This ongoing immune activation likely contributes to chronic tissue damage, marked by splenic white pulp disorganization and exacerbation of clinical signs associated with visceral leishmaniasis.</p>
<p>Furthermore, the involvement of co-expressing Arginase-1<sup>+</sup>PD-L1<sup>+</sup> cells was observed suggesting an association between M2 profile and cell exhaustion showing a cooperation by both pathways in CVL. The results of this study suggest that the predominant microbicidal response of M1 macrophages in relation to regulation by M2 macrophages, together with the blockade of cell exhaustion pathways, may be crucial for the effective control of visceral leishmaniasis. These insights could contribute to the development of more effective treatment strategies against this potentially fatal disease.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>This study received approval from the Comite&#x302; de E&#x301;tica em Uso de Animais (CEUA-Fiocruz) under license LW-54/13 and adhered to Brazilian Law 11794/08 and the guidelines of the Sociedade Brasileira de Cie&#x302;ncia em Animais de Laborato&#x301;rio (SBCAL). The access to genetic heritage was registered under number AFB4BD9 on the SisGen platform.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>Td: Formal analysis, Data curation, Validation, Methodology, Writing &#x2013; review &amp; editing, Investigation, Writing &#x2013; original draft. MS: Formal analysis, Methodology, Writing &#x2013; review &amp; editing, Validation. FR: Writing &#x2013; review &amp; editing, Methodology. FF: Writing &#x2013; review &amp; editing, Funding acquisition, Resources. AJ: Writing &#x2013; review &amp; editing, Methodology. RM: Funding acquisition, Resources, Methodology, Writing &#x2013; review &amp; editing. RP: Formal analysis, Supervision, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft, Resources, Investigation, Visualization, Validation, Funding acquisition, Project administration, Conceptualization. FM: Resources, Writing &#x2013; review &amp; editing, Funding acquisition, Writing &#x2013; original draft, Formal analysis, Validation, Data curation, Visualization, Investigation, Supervision, Methodology, Project administration, Conceptualization.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by Programa de Apoio &#xe0; Projetos Tem&#xe1;ticos no Estado do Rio de Janeiro-Faperj (E-26/211.340/2021), APQ-1-Faperj (E-26/211.595/2021), Programa Jovem Cientista do Nosso estado -Faperj (E-26/202.760/2019), Programa Cientista do Nosso Estado -FAPERJ, (E-26/204.308/2024; E-26/201.032/2021), CNPq (PQ 1D 307067/2023-8; PQ 2 308785/2021-5; Universal 408433/2023-0), PAEF-IOC-Fiocruz and Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior -Brasil (CAPES) -Finance Code 001. F.N.M., RCM and F.B.F. received productivity fellowships from CNPq.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors thank the Multiuser Research Facility of Flow Cytometry &#x2013; Multiparametric Analysis, IOC/FIOCRUZ, for their support in the sample acquisition as well as their valuable guidance on acquisition protocols.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1617751/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1617751/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document">
<label>Supplementary Table&#xa0;1</label>
<caption>
<p>Target genes and their sequences used in quantification of the parasite load. S, sense; AS, antisense, bp, base pairs.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table2.docx" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document">
<label>Supplementary Table&#xa0;2</label>
<caption>
<p>Quantitative analysis of functional markers of M1, M2 and PD-L1<sup>+</sup> macrophages according to clinical score, parasite load and splenic white pulp disorganization of dogs naturally infected with <italic>L. infantum</italic>. Data are represented as median (minimum-maximum values).</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table3.docx" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document">
<label>Supplementary Table&#xa0;3</label>
<caption>
<p>Analysis of immunological markers in spleen of dogs naturally infected with <italic>Leishmania infantum</italic> according to clinical score, parasite load and splenic white pulp disorganization using flow cytometer technique. Data are represented by median and minimum and maximum values.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image1.jpg" id="SF1" mimetype="image/jpeg">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Gate strategy. <bold>(A)</bold> Forward scatter area (FSC-A) <italic>vs</italic>. side scatter (SSC-A) dot plot with population gate (Cels.); <bold>(B)</bold> Forward scatter area (FSC-A) <italic>vs</italic>. forward scatter height (FSC-H) dot plot from gate Cels with Singlets gate; <bold>(C)</bold> Histogram of Zombie-KO525 staining within Singlets gate showing living cells (Alive). <bold>(D)</bold> Histogram of CD14-APC within Alive gate staining showing CD14<sup>+</sup> cells; <bold>(E)</bold> Histogram of Arginase-PECY7 staining within Alive gate showing Arginase-1<sup>+</sup> cells and Arginase <sup>high</sup>; <bold>(F)</bold> Histogram of PD-L1-PE staining within Alive gate showing PD-L1<sup>+</sup> cells within Alive gate.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>WHO Expert Committee on the Control of the Leishmaniases, World Health Organization</collab>
</person-group>. <source>Control of the leishmaniases: report of a meeting of the WHO Expert Commitee on the Control of Leishmaniases, Geneva, 22&#x2013;26 March 2010</source>. <publisher-loc>Ginebra</publisher-loc>: <publisher-name>Control de las leishmaniasis: informe de una reuni&#xf3;n del Comit&#xe9; de Expertos de la OMS sobre el Control de las Leishmaniasis</publisher-name> (<year>2010</year>). Available at: <uri xlink:href="https://apps.who.int/iris/handle/10665/44412">https://apps.who.int/iris/handle/10665/44412</uri> (Accessed June 11, 2025).</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Momen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Pacheco</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Cupolillo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Grimaldi J&#xfa;nior</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Molecular evidence for the importation of Old World Leishmania into the Americas</article-title>. <source>Biol Res</source>. (<year>1993</year>) <volume>26</volume>:<page-range>249&#x2013;55</page-range>.</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campos</surname> <given-names>R</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tunon</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cunha</surname> <given-names>L</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname> <given-names>L</given-names>
</name>
<name>
<surname>Moraes</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Epidemiological aspects and spatial distribution of human and canine visceral leishmaniasis in an endemic area in northeastern Brazil</article-title>. <source>Geospat Health</source>. (<year>2017</year>) <volume>12</volume>:<fpage>503</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4081/gh.2017.503</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naufal Spir</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Prestes-Carneiro</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Fonseca</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Dayse</surname> <given-names>A</given-names>
</name>
<name>
<surname>Giuffrida</surname> <given-names>R</given-names>
</name>
<name>
<surname>D&#x2019;Andrea</surname> <given-names>LAZ</given-names>
</name>
</person-group>. <article-title>Clinical characteristics and spatial distribution of Visceral leishmaniasis in children in S&#xe3;o Paulo state: an emerging focus of Visceral leishmaniasis in Brazil</article-title>. <source>Pathog Glob Health</source>. (<year>2017</year>) <volume>111</volume>:<page-range>91&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/20477724.2017.1289666</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borja</surname> <given-names>LS</given-names>
</name>
<name>
<surname>de Sousa</surname> <given-names>OMF</given-names>
</name>
<name>
<surname>Solc&#xe0;</surname> <given-names>M da S</given-names>
</name>
<name>
<surname>Bastos</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Bordoni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname> <given-names>JT</given-names>
</name>
<etal/>
</person-group>. <article-title>Parasite load in the blood and skin of dogs naturally infected by Leishmania infantum is correlated with their capacity to infect sand fly vectors</article-title>. <source>Vet Parasitol</source>. (<year>2016</year>) <volume>229</volume>:<page-range>110&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetpar.2016.10.004</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belo</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Werneck</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Sim&#xf5;es</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>BWL</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>ES</given-names>
</name>
<etal/>
</person-group>. <article-title>Factors associated with visceral leishmaniasis in the Americas: A systematic review and meta-analysis</article-title>. <source>PLoS Negl Trop Diseases</source>. (<year>2013</year>) <volume>7</volume>:<elocation-id>e2182</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0002182</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurenti</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>CN</given-names>
</name>
<name>
<surname>da Matta</surname> <given-names>VLR</given-names>
</name>
<name>
<surname>Tomokane</surname> <given-names>TY</given-names>
</name>
<name>
<surname>Corbett</surname> <given-names>CEP</given-names>
</name>
<name>
<surname>Secundino</surname> <given-names>NFC</given-names>
</name>
<etal/>
</person-group>. <article-title>Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector</article-title>. <source>Vet Parasitol</source>. (<year>2013</year>) <volume>196</volume>:<fpage>296</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetpar.2013.03.017</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boggiatto</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Ramer-Tait</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Metz</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kramer</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Gibson-Corley</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mullin</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunologic Indicators of Clinical Progression during Canine Leishmania infantum Infection</article-title>. <source>Clin Vaccine Immunol</source>. (<year>2010</year>) <volume>17</volume>:<page-range>267&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CVI.00456-09</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<article-title>Manual de vigil&#xe2;ncia e controle da leishmaniose visceral - 1<sup>a</sup>
Edi&#xe7;&#xe3;o</article-title>. (<publisher-loc>Brasil</publisher-loc>: <publisher-name>Minist&#xe9;rio da Sa&#xfa;de</publisher-name>) (<year>2014</year>). <fpage>p120</fpage>.</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solano-Gallego</surname> <given-names>L</given-names>
</name>
<name>
<surname>Koutinas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mir&#xf3;</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cardoso</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pennisi</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Ferrer</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis</article-title>. <source>Vet Parasitol</source>. (<year>2009</year>) <volume>165</volume>:<fpage>1</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetpar.2009.05.022</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Santana</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>CI</given-names>
</name>
<name>
<surname>Veras</surname> <given-names>PST</given-names>
</name>
<etal/>
</person-group>. <article-title>Low CXCL13 expression, splenic lymphoid tissue atrophy and germinal center disruption in severe canine visceral leishmaniasis</article-title>. <source>PLoS One</source>. (<year>2012</year>) <volume>7</volume>:<elocation-id>e29103</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0029103</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baneth</surname> <given-names>G</given-names>
</name>
<name>
<surname>Shaw</surname> <given-names>SE</given-names>
</name>
</person-group>. <article-title>Chemotherapy of canine leishmaniosis</article-title>. <source>Vet Parasitol</source>. (<year>2002</year>) <volume>106</volume>:<page-range>315&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0304-4017(02)00115-2</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Campino</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Cytokine and phenotypic cell profiles of Leishmania infantum infection in the dog</article-title>. <source>J Trop Med</source>. (<year>2012</year>) <volume>2012</volume>:<fpage>541571</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/541571</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santana</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Vassallo</surname> <given-names>J</given-names>
</name>
<name>
<surname>De Freitas</surname> <given-names>LAR</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>GGS</given-names>
</name>
<name>
<surname>Pontes-De-Carvalho</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Dos-Santos</surname> <given-names>WLC</given-names>
</name>
</person-group>. <article-title>Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: A study on naturally infected dogs</article-title>. <source>Parasite Immunol</source>. (<year>2008</year>) <volume>30</volume>:<page-range>515&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-3024.2008.01051.x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname> <given-names>IS</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>VA</given-names>
</name>
<name>
<surname>Junior</surname> <given-names>FGL</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Larangeira</surname> <given-names>DF</given-names>
</name>
<etal/>
</person-group>. <article-title>Severe clinical presentation of visceral leishmaniasis in naturally infected dogs with disruption of the splenic white pulp</article-title>. <source>PLoS One</source>. (<year>2014</year>) <volume>9</volume>:<elocation-id>e87742</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0087742</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nascimento</surname> <given-names>MSL</given-names>
</name>
<name>
<surname>Albuquerque</surname> <given-names>TDR</given-names>
</name>
<name>
<surname>Do-Valle-Matta</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Caldas</surname> <given-names>IS</given-names>
</name>
<name>
<surname>Diniz</surname> <given-names>LF</given-names>
</name>
<name>
<surname>Talvani</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Naturally Leishmania infantum-infected dogs display an overall impairment of chemokine and chemokine receptor expression during visceral leishmaniasis</article-title>. <source>Vet Immunol Immunopathol</source>. (<year>2013</year>) <volume>153</volume>:<page-range>202&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2013.02.015</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalcanti</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Ribeiro-Alves</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>L de OR</given-names>
</name>
<name>
<surname>Mestre</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>ABR</given-names>
</name>
<name>
<surname>Morgado</surname> <given-names>FN</given-names>
</name>
<etal/>
</person-group>. <article-title>Parasite load induces progressive spleen architecture breakage and impairs cytokine mRNA expression in Leishmania infantum-naturally infected dogs</article-title>. <source>PLoS One</source>. (<year>2015</year>) <volume>10</volume>:<elocation-id>e0123009</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0123009</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Wherry</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Masopust</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Allison</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Sharpe</surname> <given-names>AH</given-names>
</name>
<etal/>
</person-group>. <article-title>Restoring function in exhausted CD8 T cells during chronic viral infection</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>439</volume>:<page-range>682&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature04444</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eichbaum</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>PD-1 signaling in HIV and chronic viral infection&#x2013;potential for therapeutic intervention</article-title>? <source>Curr Med Chem</source>. (<year>2011</year>) <volume>18</volume>:<page-range>3971&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/092986711796957239</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joshi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Perovic</surname> <given-names>V</given-names>
</name>
<name>
<surname>Cockburn</surname> <given-names>IA</given-names>
</name>
<name>
<surname>St&#xe4;ger</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections</article-title>. <source>PLoS Pathog</source>. (<year>2009</year>) <volume>5</volume>:<elocation-id>e1000431</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1000431</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Souza</surname> <given-names>TL</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>AVA</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>LdeOR</given-names>
</name>
<name>
<surname>Figueiredo</surname> <given-names>FB</given-names>
</name>
<name>
<surname>Mendes Junior</surname> <given-names>AAV</given-names>
</name>
<name>
<surname>Menezes</surname> <given-names>RC</given-names>
</name>
<etal/>
</person-group>. <article-title>Pro-cellular exhaustion markers are associated with splenic microarchitecture disorganization and parasite load in dogs with visceral leishmaniasis</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>:<fpage>12962</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-49344-1</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bullen</surname> <given-names>DVR</given-names>
</name>
</person-group>. <article-title>Interaction of Leishmania with the host macrophage</article-title>. <source>Trends Parasitol</source>. (<year>2002</year>) <volume>18</volume>:<page-range>332&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1471-4922(02)02352-8</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chappuis</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sundar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hailu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ghalib</surname> <given-names>H</given-names>
</name>
<name>
<surname>Rijal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Peeling</surname> <given-names>RW</given-names>
</name>
<etal/>
</person-group>. <article-title>Visceral leishmaniasis: what are the needs for diagnosis, treatment and control</article-title>? <source>Nat Rev Microbiol</source>. (<year>2007</year>) <volume>5</volume>:<page-range>873&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro1748</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaye</surname> <given-names>P</given-names>
</name>
<name>
<surname>Scott</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Leishmaniasis: complexity at the host-pathogen interface</article-title>. <source>Nat Rev Microbiol</source>. (<year>2011</year>) <volume>9</volume>:<page-range>604&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro2608</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fasel</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>How to master the host immune system? Leishmania parasites have the solutions</article-title>! <source>Int Immunol</source>. (<year>2018</year>) <volume>30</volume>:<page-range>103&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxx075</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Das</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Verma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ghosh</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>l-arginine uptake by cationic amino acid transporter promotes intra-macrophage survival of Leishmania donovani by enhancing arginase-mediated polyamine synthesis</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>839</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00839</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomiotto-Pellissier</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bortoleti BT da</surname> <given-names>S</given-names>
</name>
<name>
<surname>Assolini</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Carloto</surname> <given-names>ACM</given-names>
</name>
<name>
<surname>Miranda-Sapla</surname> <given-names>MM</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage polarization in leishmaniasis: broadening horizons</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>2529</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02529</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Regulation of M1&#x2212;type and M2&#x2212;type macrophage polarization in RAW264.7 cells by Galectin&#x2212;9</article-title>. <source>Mol Med Rep</source>. (<year>2017</year>) <volume>16</volume>:<page-range>9111&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2017.7719</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavazza</surname> <given-names>A</given-names>
</name>
<name>
<surname>Triantafyllou</surname> <given-names>E</given-names>
</name>
<name>
<surname>Savoldelli</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mujib</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jerome</surname> <given-names>E</given-names>
</name>
<name>
<surname>Trovato</surname> <given-names>FM</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage activation markers are associated with infection and mortality in patients with acute liver failure</article-title>. <source>Liver Int</source>. (<year>2024</year>) <volume>44</volume>:<page-range>1900&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/liv.15928</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname> <given-names>F</given-names>
</name>
<name>
<surname>Saldarriaga</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Spratt</surname> <given-names>H</given-names>
</name>
<name>
<surname>Osorio</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Travi</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Luxon</surname> <given-names>BA</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcriptional profiling in experimental visceral leishmaniasis reveals a broad splenic inflammatory environment that conditions macrophages toward a disease-promoting phenotype</article-title>. <source>PloS Pathogens</source>. (<year>2017</year>) <volume>13</volume>:<elocation-id>e1006165</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006165</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira</surname> <given-names>PRR</given-names>
</name>
<name>
<surname>Fernando</surname> <given-names>FS</given-names>
</name>
<name>
<surname>Montassier</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Andr&#xe9;</surname> <given-names>MR</given-names>
</name>
<name>
<surname>de Oliveira Vasconcelos</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Polarized M2 macrophages in dogs with visceral leishmaniasis</article-title>. <source>Vet Parasitol</source>. (<year>2016</year>) <volume>226</volume>:<fpage>69</fpage>&#x2013;<lpage>73</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetpar.2016.06.032</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medina-Colorado</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Osorio</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Saldarriaga</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Travi</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>F</given-names>
</name>
<name>
<surname>Spratt</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Splenic CD4+ T cells in progressive visceral leishmaniasis show a mixed effector-regulatory phenotype and impair macrophage effector function through inhibitory receptor expression</article-title>. <source>PLoS One</source>. (<year>2017</year>) <volume>12</volume>:<elocation-id>e0169496</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0169496</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinnell</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Courtenay</surname> <given-names>O</given-names>
</name>
<name>
<surname>Shaw</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Day</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Garcez</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Dye</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Tissue cytokine responses in canine visceral leishmaniasis</article-title>. <source>J Infect Dis</source>. (<year>2001</year>) <volume>183</volume>:<page-range>1421&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/jid.2001.183.issue-9</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prina</surname> <given-names>E</given-names>
</name>
<name>
<surname>Roux</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mattei</surname> <given-names>D</given-names>
</name>
<name>
<surname>Milon</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR</article-title>. <source>Microbes Infect</source>. (<year>2007</year>) <volume>9</volume>:<page-range>1307&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2007.06.005</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pessenda</surname> <given-names>G</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Arginase and its mechanisms in Leishmania persistence</article-title>. <source>Parasite Immunol</source>. (<year>2020</year>) <volume>42</volume>:<elocation-id>e12722</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/pim.12722</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terrazas</surname> <given-names>LI</given-names>
</name>
<name>
<surname>Montero</surname> <given-names>D</given-names>
</name>
<name>
<surname>Terrazas</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Reyes</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Sosa</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis</article-title>. <source>Int J Parasitol</source>. (<year>2005</year>) <volume>35</volume>:<page-range>1349&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijpara.2005.06.003</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres-Ruiz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Absal&#xf3;n-Aguilar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Reyes-Islas</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Cassiano-Quezada</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mej&#xed;a-Dom&#xed;nguez</surname> <given-names>NR</given-names>
</name>
<name>
<surname>P&#xe9;rez-Fragoso</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies</article-title>. <source>Rheumatology</source>. (<year>2023</year>) <volume>62</volume>:<page-range>775&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/rheumatology/keac374</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>HH</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Song</surname> <given-names>JW</given-names>
</name>
<etal/>
</person-group>. <article-title>Increased neutrophil aging contributes to T cell immune suppression by PD-L1 and arginase-1 in HIV-1 treatment na&#xef;ve patients</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>670616</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.670616</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ukil</surname> <given-names>A</given-names>
</name>
<name>
<surname>Das</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Crosstalk of PD-1 signaling with the SIRT1/FOXO-1 axis during the progression of visceral leishmaniasis</article-title>. <source>J Cell Sci</source>. (<year>2019</year>) <volume>132</volume>:<fpage>jcs226274</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/jcs.226274</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zerdes</surname> <given-names>I</given-names>
</name>
<name>
<surname>Wallerius</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sifakis</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Wallmann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Betts</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bartish</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>STAT3 activity promotes programmed-death ligand 1 expression and suppresses immune responses in breast cancer</article-title>. <source>Cancers</source>. (<year>2019</year>) <volume>11</volume>:<fpage>1479</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers11101479</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>